BAD and cancer: ABT-737 bound BCL2, BCLxL, and BCLw with high affinity, thereby mimicking the action of BH3-only protein BAD, demonstrating the sub-micromolar killing of primary cancer cells and cancer cell lines as well as anti-tumor activity in mouse models [38,39].